NO20012190L - Heparanase aktivitetsnöytraliserende anti-heparanase monoklonalt antistoff - Google Patents

Heparanase aktivitetsnöytraliserende anti-heparanase monoklonalt antistoff

Info

Publication number
NO20012190L
NO20012190L NO20012190A NO20012190A NO20012190L NO 20012190 L NO20012190 L NO 20012190L NO 20012190 A NO20012190 A NO 20012190A NO 20012190 A NO20012190 A NO 20012190A NO 20012190 L NO20012190 L NO 20012190L
Authority
NO
Norway
Prior art keywords
heparanase
monoclonal antibody
neutralizing anti
activity neutralizing
antibody
Prior art date
Application number
NO20012190A
Other languages
English (en)
Norwegian (no)
Other versions
NO20012190D0 (no
Inventor
Tuvia Peretz
Daphna Miron
Yinon Shlomi
Iris Pecker
Maty Ayal-Hershkovitz
Yael Friedman
Israel Vlodavsky
Original Assignee
Hadasit Med Res Service
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hadasit Med Res Service filed Critical Hadasit Med Res Service
Publication of NO20012190D0 publication Critical patent/NO20012190D0/no
Publication of NO20012190L publication Critical patent/NO20012190L/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K16/00Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/40Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against enzymes
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/02Immunomodulators
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/02Immunomodulators
    • A61P37/06Immunosuppressants, e.g. drugs for graft rejection
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14Hydrolases (3)
    • C12N9/24Hydrolases (3) acting on glycosyl compounds (3.2)
    • C12N9/2402Hydrolases (3) acting on glycosyl compounds (3.2) hydrolysing O- and S- glycosyl compounds (3.2.1)
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12YENZYMES
    • C12Y302/00Hydrolases acting on glycosyl compounds, i.e. glycosylases (3.2)
    • C12Y302/01Glycosidases, i.e. enzymes hydrolysing O- and S-glycosyl compounds (3.2.1)
    • C12Y302/01166Heparanase (3.2.1.166)
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/573Immunoassay; Biospecific binding assay; Materials therefor for enzymes or isoenzymes
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/505Medicinal preparations containing antigens or antibodies comprising antibodies
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/90Enzymes; Proenzymes
    • G01N2333/988Lyases (4.), e.g. aldolases, heparinase, enolases, fumarase
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2400/00Assays, e.g. immunoassays or enzyme assays, involving carbohydrates
    • G01N2400/10Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • G01N2400/38Heteroglycans, i.e. polysaccharides having more than one sugar residue in the main chain in either alternating or less regular sequence, e.g. gluco- or galactomannans, Konjac gum, Locust bean gum or Guar gum
    • G01N2400/40Glycosaminoglycans, i.e. GAG or mucopolysaccharides, e.g. chondroitin sulfate, dermatan sulfate, hyaluronic acid, heparin, heparan sulfate, and related sulfated polysaccharides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Biomedical Technology (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biophysics (AREA)
  • Cell Biology (AREA)
  • Pathology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Food Science & Technology (AREA)
  • General Physics & Mathematics (AREA)
  • Pain & Pain Management (AREA)
  • Transplantation (AREA)
  • Rheumatology (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
NO20012190A 1998-11-04 2001-05-03 Heparanase aktivitetsnöytraliserende anti-heparanase monoklonalt antistoff NO20012190L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US09/186,200 US6562950B2 (en) 1997-09-02 1998-11-04 Heparanase activity neutralizing anti-heparanase monoclonal antibody
PCT/US1999/025451 WO2000025817A1 (en) 1998-11-04 1999-10-28 Heparanase activity neutralizing anti-heparanase monoclonal antibody

Publications (2)

Publication Number Publication Date
NO20012190D0 NO20012190D0 (no) 2001-05-03
NO20012190L true NO20012190L (no) 2001-06-12

Family

ID=22684036

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20012190A NO20012190L (no) 1998-11-04 2001-05-03 Heparanase aktivitetsnöytraliserende anti-heparanase monoklonalt antistoff

Country Status (11)

Country Link
US (2) US6562950B2 (es)
EP (1) EP1126878B1 (es)
JP (1) JP2002543759A (es)
AT (1) ATE442859T1 (es)
AU (1) AU751170B2 (es)
CA (1) CA2349622A1 (es)
DE (1) DE69941435D1 (es)
ES (1) ES2332960T3 (es)
IL (1) IL142866A0 (es)
NO (1) NO20012190L (es)
WO (1) WO2000025817A1 (es)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6177545B1 (en) * 1997-09-02 2001-01-23 Insight Strategy & Marketing Ltd. Heparanase specific molecular probes and their use in research and medical applications
US20040213789A1 (en) * 1997-09-02 2004-10-28 Oron Yacoby-Zeevi Heparanase activity neutralizing anti-heparanase monoclonal antibody and other anti-heparanase antibodies
US6699672B1 (en) * 1997-09-02 2004-03-02 Insight Biopharmaceuticals Ltd. Heparanase specific molecular probes and their use research and medical applications
US20020088019A1 (en) * 1997-09-02 2002-07-04 Oron Yacoby-Zeevi Methods of and pharmaceutical compositions for improving implantation of embryos
US20030161823A1 (en) * 1998-08-31 2003-08-28 Neta Ilan Therapeutic and cosmetic uses of heparanases
US20030217375A1 (en) * 1998-08-31 2003-11-20 Eyal Zcharia Transgenic animals expressing heparanase and uses thereof
AU2878600A (en) * 1999-03-01 2000-09-21 Hadasit Medical Research Services & Development Company Ltd Polynucleotide encoding a polypeptide having heparanase activity and expression of same in genetically modified cells
US6784288B2 (en) * 2001-11-08 2004-08-31 Ortho-Mcneil Pharmaceutical, Inc. Polynucleotide and polypeptide sequences of monkey cathepsin S
AU2003295411A1 (en) * 2002-11-07 2004-06-03 Celltech R & D Human monoclonal antibodies to heparanase
US20060269552A1 (en) * 2003-06-09 2006-11-30 Oron Yacoby-Zeevi Heparanase activity neutralizing anti-heparanase monclonal antibody and other anti-heparanase antibodies
IL160025A0 (en) * 2004-01-22 2004-06-20 Hadasit Med Res Service Heparanase inhibitors directed against a specific sequence essential for heparanase catalytic activity and uses thereof
US7391863B2 (en) * 2004-06-23 2008-06-24 Vocollect, Inc. Method and system for an interchangeable headset module resistant to moisture infiltration
USD549694S1 (en) 2005-11-15 2007-08-28 Vocollect, Inc. Headset
USD552595S1 (en) 2005-11-16 2007-10-09 Vocollect, Inc. Control panel for a headset
US8417185B2 (en) 2005-12-16 2013-04-09 Vocollect, Inc. Wireless headset and method for robust voice data communication
US7885419B2 (en) 2006-02-06 2011-02-08 Vocollect, Inc. Headset terminal with speech functionality
US7773767B2 (en) 2006-02-06 2010-08-10 Vocollect, Inc. Headset terminal with rear stability strap
IL184671A0 (en) * 2007-07-17 2008-12-29 Hadasit Med Res Service Substances directed to heparanase c-terminal domain-or substance derived therefrom and uses thereof as modulators of heparanas biological activities
USD605629S1 (en) 2008-09-29 2009-12-08 Vocollect, Inc. Headset
WO2010041060A1 (en) * 2008-10-08 2010-04-15 Medimmune Limited Targeted binding agents directed to heparanase and uses thereof 463
US8160287B2 (en) 2009-05-22 2012-04-17 Vocollect, Inc. Headset with adjustable headband
US8438659B2 (en) 2009-11-05 2013-05-07 Vocollect, Inc. Portable computing device and headset interface
US9428586B2 (en) * 2009-12-01 2016-08-30 Compugen Ltd Heparanase splice variant
EP3362093A4 (en) 2015-10-13 2019-05-08 Technion Research & Development Foundation Limited HEPARANASE-NEUTRALIZING MONOCLONAL ANTIBODIES
BR112019012045A2 (pt) 2016-12-13 2020-08-18 Beta Therapeutics Pty Ltd inibidores de heparanase e uso dos mesmos
US11787783B2 (en) 2016-12-13 2023-10-17 Beta Therapeutics Pty Ltd Heparanase inhibitors and use thereof
EP4175670A4 (en) 2020-07-06 2024-07-24 Technion Research & Development Foundation Limited Heparanase-neutralizing a54 monoclonal antibody

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5262403A (en) * 1986-03-10 1993-11-16 Board Of Regents, The University Of Texas System Glycosaminoglycan derivatives and their use as inhibitors of tumor invasiveness of metastatic profusion-II
US4859581A (en) * 1986-03-10 1989-08-22 Board Of Regents, The University Of Texas System Endoglycosidase assay
ATE167230T1 (de) * 1989-08-23 1998-06-15 Hadassah Med Org Wundheilmittel enthaltend heparanase
US5736137A (en) * 1992-11-13 1998-04-07 Idec Pharmaceuticals Corporation Therapeutic application of chimeric and radiolabeled antibodies to human B lymphocyte restricted differentiation antigen for treatment of B cell lymphoma
US6177545B1 (en) * 1997-09-02 2001-01-23 Insight Strategy & Marketing Ltd. Heparanase specific molecular probes and their use in research and medical applications
US20040213789A1 (en) * 1997-09-02 2004-10-28 Oron Yacoby-Zeevi Heparanase activity neutralizing anti-heparanase monoclonal antibody and other anti-heparanase antibodies
JP2002510462A (ja) * 1997-10-28 2002-04-09 ジ・オーストラリアン・ナショナル・ユニバーシティー 哺乳類のエンドグルクロニダーゼをコードする単離された核酸分子およびその使用
GB9802725D0 (en) * 1998-02-09 1998-04-08 Ciba Geigy Ag Organic compounds

Also Published As

Publication number Publication date
AU751170B2 (en) 2002-08-08
JP2002543759A (ja) 2002-12-24
NO20012190D0 (no) 2001-05-03
US6946131B2 (en) 2005-09-20
EP1126878A4 (en) 2003-04-16
WO2000025817A1 (en) 2000-05-11
CA2349622A1 (en) 2000-05-11
DE69941435D1 (de) 2009-10-29
US20030181687A1 (en) 2003-09-25
US6562950B2 (en) 2003-05-13
ATE442859T1 (de) 2009-10-15
EP1126878B1 (en) 2009-09-16
US20020068061A1 (en) 2002-06-06
ES2332960T3 (es) 2010-02-15
EP1126878A1 (en) 2001-08-29
IL142866A0 (en) 2002-03-10
AU1331400A (en) 2000-05-22

Similar Documents

Publication Publication Date Title
NO20012190D0 (no) Heparanase aktivitetsnöytraliserende anti-heparanase monoklonalt antistoff
NO20013561L (no) Oljer med heterogene kjedelengder
PL353750A1 (en) Dosages for treatment with anti-erbb2 antibodies
EP1069185A4 (en) HUMANIZED ANTIBODY TO THE HUMAN TISSUE FACTOR (TF) AND METHOD FOR THE CONSTRUCTION OF SUCH A HUMANIZED ANTIBODY.
GB2368796A (en) Humanized anti-ErbB2 antibodies and treatment with anti-ErbB2 antibodies
DE69632630D1 (de) Enzym mit aminopeptidaseactivität
EA199900758A1 (ru) Малые молекулы, полезные при лечении воспалительных заболеваний
ES2133727T3 (es) Derivados de acido hidroxamico como inhibidores de metaloproteinasa.
ES2164182T3 (es) Benzociclopentanoxazolidinonas que contienen heteroatomos con actividad antibacteriana.
ES2159318T3 (es) Inhibidores de la proteina quinasa c.
NO960684D0 (no) Monoklonalt antistoff som induserer apoptose
NO975690D0 (no) Fremgangsmåte for forbedring av dyrehelse
DE69801660D1 (de) Lokale behandlung von psoriasis unter verwendung neutralisierender antikörper gegen il-8
IS6105A (is) Aðferð til meðferðar á netjuhersli með notkun mótlyfs við integríninu alfa-4
AR015837A1 (es) Metodo de transformacion de plantas.
WO2004034972A3 (en) Compounds, compositions, and methods
ES2080037T1 (es) Medicamento de uso topico con actividad cicatrizante.
MXPA02006167A (es) Promocion de la angiogenesis con survivina.
EA199800864A1 (ru) Способ лечения при боли, вызванной мигренью
WO2001087239A3 (en) Methods of affecting laminin 5 processing
DK1237562T3 (da) Fremgangsmåde til fremstilling af mikania-ekstrakter, som indeholder mikanolid og dihydromikanolid, og anvendelse i behandlingen af prolifererende sygdomme
WO1998046632A3 (de) Inhibitoren für den urokinaserezeptor
WO2004108065A3 (en) Heparanase activity neutralizing anti- heparanase monoclonal antibody and other anti-heparanase antibodies
ATE380869T1 (de) Fcyriia-transgenes tiermodell für autoimmunkrankheit
NO913281L (no) Vandig loesning, saerlig til rensing av hoeyfasthetsstaal.

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application